“Regulatory oversight of vaccines is critically important. It is the government's primary method of ensuring that the vaccines produced and used in China are safe, of good quality and effective,” said Gauden Galea, WHO Representative for China. “This incident shows that when regulatory oversight works well, potential risks can be averted.”

（图）：世界卫生组织关于中国狂犬病疫苗事件的媒体声明。图片来自互联网与傻大方资讯无关。

Good manufacturing and regulatory practices are designed to prevent problems in the process of ensuring quality vaccines. But when problems are found, the regulator must take action. WHO commends the quick and transparent actions taken by China NDA to suspend production at the company and investigate these incidents.

WHO assessed the national regulatory authorities in 2010 and 2014, and found that they met WHO criteria as a functional regulator for vaccines with a clear commitment to continual improvement. WHO welcomes the fact that China's NDA continues to work with WHO's Regulatory Systems Strengthening program, as it has been doing for nearly 20 years. While the current incident is clearly regrettable, the detection of this event by an unannounced inspection shows that the regulatory authority’s system of checks and balances to protect population health is working.

• 今天是世界阿尔茨海默病日，他们需要你的陪伴
• 每天吃个它，胜吃10个苹果！降血脂，降血压，控血糖！全世界都爱
• 2018（首届）世界川菜大会 双流展馆让你看得垂涎三尺
• 卫生组织鉴定：已明确致癌4种蔬菜，尤其最后一种，饿不死就别碰
• 世界上耐力最强的人类，53岁连跑80个小时，网友：这持久力服
• 卫生组织查明：全身都“致癌”的4种蔬菜，最后一种饿死也别吃了
• 三千女子共跳汉服舞 创吉尼斯世界纪录
• 民歌美妙 世界知道——南宁国际民歌艺术节二十载唱出文化自
• 专注尿道修复技术 世界顶尖专家推荐上海六院Dr.Fu
• 世界上恐怖的减肥法，快来了解一下，它们真的有效吗？